Search Results

DMXAA (Vadimezan) 100mg  | 97%

APEXBIO TECHNOLOGY LLC

Tumnor vascular disrupting agent, apoptosis inducer Angiogenesis|VDA

More Information Supplier Page

×

DMXAA (Vadimezan)

Erlotinib Hydrochloride 10mM (in 1mL DMSO)  | 99.55%

APEXBIO TECHNOLOGY LLC

Selective EGFR inhibitor JAK/STAT Signaling|EGFR

More Information Supplier Page

×

Erlotinib Hydrochloride

Erlotinib Hydrochloride 1g  | 99.55%

APEXBIO TECHNOLOGY LLC

Selective EGFR inhibitor JAK/STAT Signaling|EGFR

More Information Supplier Page

×

Erlotinib Hydrochloride

Erlotinib Hydrochloride 5g  | 99.55%

APEXBIO TECHNOLOGY LLC

Selective EGFR inhibitor JAK/STAT Signaling|EGFR

More Information Supplier Page

×

Erlotinib Hydrochloride

DMXAA (Vadimezan) 5mg  | 97%

APEXBIO TECHNOLOGY LLC

Tumnor vascular disrupting agent, apoptosis inducer Angiogenesis|VDA

More Information Supplier Page

×

DMXAA (Vadimezan)

DMXAA (Vadimezan) Evaluation Sample  | 97%

APEXBIO TECHNOLOGY LLC

Tumnor vascular disrupting agent, apoptosis inducer Angiogenesis|VDA

More Information Supplier Page

×

DMXAA (Vadimezan)

DMXAA (Vadimezan) 10mM (in 1mL DMSO)  | 97%

APEXBIO TECHNOLOGY LLC

Tumnor vascular disrupting agent, apoptosis inducer Angiogenesis|VDA

More Information Supplier Page

×

DMXAA (Vadimezan)

Nilotinib(AMN-107) 1g  | 99.85%

APEXBIO TECHNOLOGY LLC

Bcr-Abl kinase inhibitor,selective TGF-β / Smad Signaling|Bcr-Abl

More Information Supplier Page

×

Nilotinib(AMN-107)

Nilotinib(AMN-107) 500mg  | 99.85%

APEXBIO TECHNOLOGY LLC

Bcr-Abl kinase inhibitor,selective TGF-β / Smad Signaling|Bcr-Abl

More Information Supplier Page

×

Nilotinib(AMN-107)

ML161 50mg  | 97%

APEXBIO TECHNOLOGY LLC

PAR1 inhibitor Angiogenesis|PAR1

More Information Supplier Page

×

ML161